Intermediate Fibroblastic Neoplasm — Trials

Intermediate Fibroblastic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

128 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07170644	A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)	active not recruiting	Phase 2	20	SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, GermanyINDUSTRY	1	Sep 15, 2026	clinicaltrials
NCT04195399	A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery	active not recruiting	Phase 2	31	Children's Oncology GroupNETWORK	5